Zafrens

Zafrens, a San Diego, California based biotech company founded in 2021 by Swamy Vijayan, PhD, focuses on bridging biology, chemistry, and engineering, enabling experiments at a scale previously affordable only to big pharma. Zafrens was established with a mission to revolutionize drug discovery by leveraging nanofabrication technology for high-throughput, multi-modal cell analysis. Its proprietary platform is powered by machine learning and allows scientists to create and test hundreds of thousands of potential medicines in a single experiment, significantly reducing the time and cost of finding new treatments while providing deeper insights into drug-cell interactions. Zafrens platform is agnostic to perturbations, supporting CRISPR, CAR-T, mRNA libraries, and chemical libraries, mapping molecular responses to cell function and interactions.

Founder & CEO: Swamy Vijayan, PhD

‍